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ABSTRACT
Circulating leptin secreted from adipocytes is correlated with fat
mass and plasma insulin concentrations in humans and rodents.
Plasma leptin, insulin, and glucose decrease during fasting and in-
crease after refeeding; however, the underlying mechanisms regu-
lating the changes of leptin secretion are not known. To investigate
the role of insulin-stimulated glucose metabolism in the regulation of
leptin secretion, we examined the effects of insulin and inhibitors of
glucose transport and metabolism on leptin secretion from rat adi-
pocytes in primary culture. Insulin (0.16–16 nM) increased leptin
secretion over 96 h; however, the increase in leptin was more closely
related to the amount of glucose taken up by the adipocytes (r 5 0.64;
P , 0.0001) than to the insulin concentration per se (r 5 0.20; P ,
0.28), suggesting a role for glucose transport and/or metabolism in
regulating leptin secretion.
2-Deoxy-D-glucose (2-DG), a competitive inhibitor of glucose trans-
port and phosphorylation, caused a concentration-dependent (2–50
mg/dl) inhibition of leptin release in the presence of 1.6 nM insulin.
The inhibitory effect of 2-DG was reversed by high concentrations of
glucose. Two other inhibitors of glucose transport, phloretin (0.05–
0.25 mM) and cytochalasin-B (0.5–50 mM), also inhibited leptin secre-
tion. Inhibition of leptin secretion by these agents was proportional
to the inhibition of glucose uptake (r 5 0.60 to 0.86; all P , 0.01). Two
inhibitors of glycolysis, iodoacetate (0.005–1.0 mM) and sodium flu-
oride (0.1–5 mM), produced concentration-dependent inhibition of lep-
tin secretion in the presence of 1.6 nM insulin. In addition, both 2-DG
and sodium fluoride markedly decreased the leptin (ob) messenger
RNA content of cultured adipocytes, but did not affect 18S ribosomal
RNA content.
We conclude that glucose transport and metabolism are important
factors in the regulation of leptin expression and secretion and that
the effect of insulin to increase adipocyte glucose utilization is likely
to contribute to insulin-stimulated leptin secretion. Thus, in vivo,
decreased adipose glucose metabolism may be one mechanism by
which fasting decreases circulating leptin, whereas increased adipose
glucose metabolism would increase leptin after refeeding. (Endocri-
nology 139: 551–558, 1998)
THE ADIPOCYTE hormone, leptin is implicated in theregulation of food intake, energy expenditure, and
body fat stores (1). Circulating leptin decreases after fasting
or caloric restriction in both humans (2–4) and rodents (5–7),
and increases a number of hours after refeeding (3, 6). In
humans, there is a nocturnal rise of plasma leptin (8), which
has been hypothesized to be due to a delayed effect of insulin
released during earlier meals. Consistent with this hypoth-
esis, insulin increases expression of the ob gene in rodents
(9–11) and in adipocytes in vitro (12, 13) after a number of
hours. In humans, plasma insulin and leptin concentrations
decrease in parallel after weight loss, independently of
changes of adiposity (14). Furthermore, plasma leptin is neg-
atively correlated with insulin sensitivity independently of
adiposity in subjects with impaired glucose tolerance (15).
Short term insulin administration does not affect plasma
leptin concentrations in human subjects (16, 17), but in-
creases in circulating leptin have been reported after 4–6 h
of high dose insulin administration (18, 19). These studies by
necessity require the infusion of large amounts of glucose to
prevent hypoglycemia. Similarly, prolonged hyperglycemia
in response to extended glucose infusions increases plasma
leptin after several hours in nonhuman primates (20) and
human subjects (21); however, glucose administration also
markedly increases endogenous insulin levels. Therefore, the
role of insulin per se on the adipocyte vs. the effect of insulin
to increase glucose flux into adipocytes was not addressed by
these experiments.
Several lines of evidence have led us to hypothesize that
glucose is an important regulator of leptin expression and
secretion. First, increases in ob messenger RNA (mRNA) after
glucose administration in mice are more closely related to
plasma glucose concentrations than to plasma insulin con-
centrations (22). Second, infusion of small amounts of glu-
cose to prevent the decline of glycemia during fasting in
humans also prevents the decrease in plasma leptin (2).
Third, the decrease in plasma leptin during marked caloric
restriction in humans is better correlated with the decrease
in plasma glucose than with changes in insulinemia (4).
Fourth, we have found that low plasma leptin levels in strep-
tozotocin diabetic rats are acutely increased by insulin ad-
ministration in proportion to the degree of glucose lowering
(23). Lastly, lowering plasma glucose concentrations in hy-
perglycemic insulin-dependent diabetic human subjects by
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infusing insulin at rates that produced physiological insu-
linemia increases circulating leptin (24).
To investigate the mechanisms by which glucose influ-
ences leptin secretion, we adapted and modified an in vitro
system for culturing rat adipocytes in which the adipocytes
are anchored in a defined mixture of extracellular matrix
components (25) This matrix, Matrigel, appears to simulate
normal basement membrane attachment of cells and may
allow cell to cell interactions between adipocytes. Cells cul-
tured in this system are, therefore, in an environment closer
to their normal physiological milieu than in systems where
adipocytes are free floating in the culture medium. Adipo-
cytes cultured on Matrigel have been shown to maintain
many of their differentiated characteristics and, in contrast
with free-floating adipocytes, show no sign of dedifferenti-
ation after 6 days of culture (25, 26). With this system we have
investigated the regulation of leptin secretion by glucose and
insulin and the effects of inhibitors of adipocyte glucose
transport and metabolism on leptin secretion. The leptin (ob)
mRNA content of the adipocytes after culture with insulin
and inhibitors was also examined.
Materials and Methods
Materials
DMEM and FBS were purchased from Life Technologies (Grand
Island, NY). The media were supplemented with 6 ml each of MEM
nonessential amino acids, penicillin/streptomycin (5000 U/ml/5000
mg/ml), and nystatin (10,000 U/ml; all from Life Technologies) per 500
ml DMEM. BSA fraction V, HEPES, collagenase (Clostridium histolyticum;
type II, Sigma Chemical Co., St. Lousi, MO; SA, 456 U/mg), insulin,
d-glucose, sodium fluoride (NaFl), phloretin, iodoacetate, and fructose
were purchased from Sigma Chemical Co. Matrigel matrix was pur-
chased from Becton Dickinson (Franklin Lakes, NJ). 2-Deoxy-d-glucose
(2-DG) was obtained from U.S. Biochemical Corp. (Cleveland, OH).
Six-well Falcon tissue culture plates were purchased from Fisher Sci-
entific (Pittsburgh, PA). Nylon filters were purchased from Tetko (Kan-
sas City, MO).
Animals
Male Sprague-Dawley rats were obtained from Charles River (Wilm-
ington, MA). Animals were housed in hanging wire cages in temper-
ature controlled rooms (22–24 C) with a 12-h light-dark cycle and fed
Purina chow diet (Ralston-Purina, St. Louis, MO) and given deionized
water ad libitum. The study protocol was approved by the University of
California-Davis animal care and use committee.
Cell isolation/preparation
Adipocytes were prepared from epididymal fat pads of male Spra-
gue-Dawley rats (300–600 g) anesthetized with halothane. Epididymal
fat depots were resected under aseptic conditions, and adipocytes were
isolated by collagenase digestion according to the Rodbell procedure
(27) with minor modifications as described below. The fat pads were
minced into pieces in Krebs-Ringer HEPES buffer (pH 7.4; containing 5
mm d-glucose, 2% BSA, 135 mm NaCl, 2.2 mm CaCl2.2H2O, 1.25 mm
MgSO4z7H2O, 0.45 mm KH2PO4, 2.17 mm Na2HPO4, and 10 mm HEPES).
Adipose tissue fragments were digested in the same buffer in the pres-
ence of type II collagenase (2.5 mg/2 ml bufferzg tissue) at 37 C with
gentle shaking at 60 cycles/min for 45 min. The resulting cell suspension
was diluted in 24 ml cold HEPES-phosphate buffer. Isolated adipocytes
were separated from undigested tissue by filtration through a 400-mm
nylon mesh and washed three times. For washing, cells were centrifuged
at 500 rpm for 5 min. Each time the infranatant was discarded, and the
adipocytes were resuspended in Krebs-Ringer HEPES buffer, with the
final wash being in 0, 5, or 10 mm glucose culture medium supplemented
with 1% or 5% FBS. The isolated adipocytes were then incubated for 30
min at 37 C before being plated in Matrigel-coated culture plates.
Adipocyte culture
Matrigel was thawed on ice to a liquid and uniformly applied to the
surface of the culture dish (300 ml Matrigel/35-mm well). After the
incubation, 150 ml of the adipocyte suspension (2:1 ratio of packed cells
to medium) were plated on the liquid matrix. The warmth of the cells
and buffer caused the Matrigel to gel around the adipocytes, effectively
anchoring them to the culture dish. After a 30-min incubation at 37 C,
2 ml warm culture medium supplemented with FBS were added. The
cells were maintained in an incubator at 37 C in 6% CO2 for 96 h.
The initial medium concentration of glucose for the cultures con-
ducted in the insulin dose-response experiment was 10.0–10.5 mm (180–
190 mg/dl) to ensure that the cells would not deplete the glucose supply
during the 96-h incubation when higher concentrations of insulin were
used. Only 1% FBS was used in the insulin dose-response study to
minimize the small amount of insulin present in the serum, which at 1%
was less than 0.1 mU/ml. In the fructose study, medium made with
glucose-free DMEM and 1% fetal serum was used to minimize the
amount of glucose available to the adipocytes (,0.1 mmol/liter). How-
ever, it was not possible to eliminate all glucose from culture preparation
because the Matrigel matrix itself contains ;4.2 mmol/liter glucose. For
the fructose experiment, the Matrigel was diluted 1:2 with glucose-free
medium to approximately 1.5 mmol/liter glucose.
In the other experiments with inhibitors of glucose transport, 2-DG
(28), phloretin (29), and cytochalasin B (30), or with inhibitors of gly-
colysis, iodoacetate (31), and NaFl (32), the initial medium glucose
concentration was (5.0–5.5 mm; 90–100 mg/dl) with 5% fetal serum.
These agents were used at concentrations at or below those typically
employed to inhibit glucose transport or glycolysis in adipocytes (28–
32). Cytochalasin B was initially dissolved in ethanol and diluted to 0.5%
ethanol in the well with the highest dose. Therefore, the medium in all
wells in the cytochalasin B experiment was equalized to 0.5% ethanol.
Aliquots of adipocytes from each animal were divided into wells with
the responses to insulin, the various inhibitors, or fructose being com-
pared with those of an appropriate control well containing adipocytes
from the same animal. In a preliminary insulin dose-response study, we
found that medium leptin concentrations in the presence of insulin were
not increased over those in control medium (no insulin) until after 24 h
of incubation. Therefore, for the remainder of the studies, 300-ml samples
(15% of the medium volume) were collected at 24, 48, 72, and 96 h and
replaced with 300 ml fresh medium containing the appropriate concen-
trations of glucose, insulin, and/or inhibitors. Cultures were observed
daily with a phase contrast microscope. After 96 h, a subset of the culture
plates was frozen until analyzed for leptin (ob) mRNA content by
Northern blot.
Assays
Leptin concentrations in the medium were determined with a sen-
sitive and specific RIA for mouse leptin as previously described (7)
(Linco Research, St. Charles, MO). Leptin concentrations in medium
from cultured rat adipocytes measured with this assay are very similar
to those obtained with a newly developed assay specific for rat leptin.
With the rat-specific assay, measured leptin concentrations in culture
medium were 86 6 3% of the mouse values and were highly correlated
between the two assays (r 5 0.97; P , 0.0001; unpublished data). There-
fore, measurements of rat leptin made with the mouse assay provide a
reliable measurement of leptin concentrations. The intra- and interassay
coefficients of variation for this assay are 4.0% and 11.2%, respectively
(7). The antibody used in the assay does not cross-react with insulin,
proinsulin, glucagon, pancreatic polypeptide or somatostatin. Glucose
and lactate were measured with a YSI glucose analyzer (model 2300,
Yellow Springs Instruments, Yellow Springs, OH).
Northern blot procedure
The following procedures were performed on culture plates incu-
bated with 5 mm glucose and 5% fetal serum alone (control), 1.6 nm
insulin, and 1.6 nm insulin with 10 mg/dl 2-DG or 1 mm NaFl for 48 and
96 h. Northern blot analysis was performed as previously described (33).
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In brief, 1 ml RNAzol B (Tel-Test, Friendswood, TX) was added directly
to the wells containing the adipocytes and matrix. The solution was
repetitively taken in and expelled from the pipette to maximize disso-
lution of the adipose tissue. UV absorbance and integrity gels were used
to estimate RNA. To allow loading of equal mass of RNA in each well,
after analysis of leptin mRNA using a single-stranded complementary
DNA probe followed by quantification of bands on a phosphoimager as
well as from film, the blots were reanalyzed using a probe complemen-
tary to mouse 18S ribosomal RNA. Leptin mRNA was then normalized
with respect to the 18S ribosomal signal, according to the absolute signal.
The 18S RNA results were virtually identical in all cases. In particular,
experimental conditions did not influence the 18S ribosomal signal.
Calculations and data analysis
The uptake of glucose was assessed by measuring the concentration
of glucose in the medium in each well before and after 96 h of incubation
and calculating the decrease over 96 h. To examine the relationship
between adipocyte carbon flux and leptin secretion in response to in-
creased insulin-mediated glucose uptake, the amount of carbon released
as lactate per amount of carbon taken up as glucose over 96 h was
calculated as D[lactate]/D[glucose], where D is the change, and ex-
pressed as a percentage. The area under the curve for leptin concen-
trations in the medium between 0–96 h was calculated by the trapezoidal
method. The means of two groups were compared by paired t test. The
means of more than two groups were compared by ANOVA. To examine
the relationships between the medium concentrations of insulin or in-
hibitors employed, the amount of glucose taken up by the adipocytes,
and leptin secretion, simple and multiple linear regression analyses were
performed with a statistics software package (StatView for Macintosh,
Abacus Concepts, Inc., Berkeley, CA). Data are expressed as the mean 6
sem.
Results
Responses to insulin (0.16–16.0 nM)
The effects of insulin on leptin secretion, and the relation-
ship between glucose uptake by adipocytes cultured with
different concentrations of insulin and leptin secretion were
examined. Insulin produced a concentration-dependent in-
crease in glucose uptake by the cultured adipocytes (r 5 0.61;
P , 0.0002 vs. insulin concentration), as assessed by the
decrease in glucose in the medium (Fig. 1A). With no added
insulin, the medium glucose concentration decreased from
10.1 6 0.1 to 8.2 6 0.3 mmol/liter (D, 21.9 6 0.3 mmol/liter;
P , 0.0001). The addition of 0.16, 1.6, and 16.0 nm insulin
increased glucose uptake (Dglucose, 22.7 6 0.4, 23.3 6 0.3,
and 23.9 6 0.4 mmol/liter, respectively; all P , 0.01 vs. no
insulin). Insulin also produced a concentration-dependent
increase in lactate production (r 5 0.70; P , 0.0001), which
was well correlated with the decrease in glucose in the me-
dium over 96 h (r 5 0. 61; P , 0.0002), suggesting that a
significant portion of the glucose entering the adipocytes was
metabolized only as far as lactate and released from the cells
into the medium (34, 35).
Leptin secretion was increased over the control value by
all three concentrations of insulin (Fig. 1B). The production
of lactate was not related to the leptin response (r 5 0.10; P 5
0.59). The area under the leptin concentration curve (AUC)
from 0–96 h was independently related to the decrease in
glucose in the medium during the incubation (Fig. 1C), but
not to the insulin concentration (Table 1). Similarly, with a
multiple regression model, the AUC for leptin was related to
the decrease in glucose, but not to the insulin concentration.
In addition, the percentage of carbon released as lactate per
amount of carbon taken up as glucose was calculated. Over-
FIG. 1. A, Glucose concentrations in medium from 0–96 h from iso-
lated rat adipocytes in primary culture with insulin concentrations
from 0–16 nM (n 5 8/treatment). B, Leptin concentrations from 0–96
h from isolated rat adipocytes in primary culture with insulin con-
centrations from 0–16 nM (n 5 8/treatment). C, Relationship between
glucose uptake, as assessed by the decrease in glucose in the culture
medium, and leptin secretion, expressed as the AUC from 0–96 h,
during incubation of adipocytes with 0–16 nM insulin (n 5 32).
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all, in the insulin experiment between 10–68% of the amount
of carbon taken up as glucose was released as lactate (mean,
34 6 2%). There was no direct relationship between this
parameter and the insulin concentration; however, it was
inversely proportional to the amount of leptin secreted, as
expressed by the 0–96 h leptin AUC (r 5 0.64; P , 0.0001).
By multiple regression analysis, the relationship between
glucose conversion to lactate and leptin secretion was not
significantly related to lactate production (P 5 0.06), but
leptin secretion was equally related to both the change in
glucose and the amount of glucose carbon released as lactate
(both P , 0.001).
Effects of 2-DG (2–50 mg/dl)
The effect of inhibiting glucose uptake and metabolism
with 2-DG on leptin secretion and its relationship to adipo-
cyte glucose uptake were examined. 2-DG at a concentration
of 50 mg/dl completely inhibited glucose uptake (D, 0.1 6 0.3
mmol/liter) in the presence of 1.6 nm insulin (Dglucose,
24.0 6 0.6 mmol/liter) and inhibited the leptin response
(AUC 0–96 h) by 69 6 4% (P , 0.0001) compared with insulin
alone (Fig. 2A). At a lower concentration of 2-DG (10 mg/dl),
glucose uptake was still markedly inhibited (D, 20.1 6 0.4
mmol/liter) and leptin secretion was inhibited by 47 6 5%
(P , 0.0001). The lowest concentration of 2-DG (2 mg/dl)
produced less of an inhibition of glucose uptake (D, 21.5 6
0.9 mmol/liter; P , 0.01 vs. insulin alone). At this concen-
tration, the leptin response was not significantly inhibited
until the 96 h point (P , 0.02 vs. insulin alone; Fig. 2A).
Overall, the change in leptin at 96 h was related to the
concentration of 2-DG and was well correlated with the de-
crease in medium glucose (Table 1). By multiple regression,
the leptin concentration in the medium at 96 h was signifi-
cantly correlated with the change in glucose, but not to the
2-DG concentration (Table 1). The addition of glucose (55.5
mm) at 48 h reversed the inhibition of leptin secretion pro-
duced by 2-DG at 10 mg/dl by 96 h (P , 0.01 vs. 2-DG; NS
vs. insulin alone; Fig. 2).
Effects of phloretin (0.05–0.25 mM)
The effect of inhibiting glucose uptake with phloretin on
leptin secretion was examined. Phloretin at a concentration
of 0.25 mm completely inhibited leptin secretion (Fig. 3). The
0–96 h AUC for leptin was inhibited by 91 6 2% of insulin
alone (P , 0.0001). This higher concentration of phloretin
(0.25 mm) also completely blocked glucose uptake in the
FIG. 2. Effects of inhibiting glucose transport and metabolism with
2-DG on leptin concentrations from 0–96 h in medium from isolated
rat adipocytes in primary culture for 96 h with 1.6 nM insulin and the
effect of adding glucose (55 mM) at 48 h on the inhibition of leptin
secretion produced by 10 mg/dl 2-DG.
FIG. 3. Effects of inhibiting glucose transport with phloretin on leptin
concentrations from 0–96 h in medium from isolated rat adipocytes
in primary culture for 96 h with 1.6 nM insulin and the effect of adding
glucose (55 mM) at 48 h on the inhibition of leptin secretion produced
by 0.25 mM phloretin.
TABLE 1. Relationship between glucose uptake (DGluc), leptin secretion (DLept) and the concentration of insulin or inhibitors of glucose
uptake and metabolism after 96-h incubation of adipocytes with insulin and insulin plus inhibitors (2-DG, phloretin, cytochalasin-B,
iodocetate, or sodium fluoride at varying concentrations; see Materials and Methods)
Insulin or inhibitor (n)
Simple Regression Multiple regression
DLept vs. DGluc DLept vs. [inhibitor] DLept vs. DGluc
(P)
DLept vs. [inhibitor]
(P)r P r P
Insulin (32) 0.64 0.0001 0.20 0.28 0.0001 0.09
2-DG (38) 0.67 0.0001 0.51 0.001 0.001 0.29
Phloretin (38) 0.86 0.0001 0.78 0.0001 0.0012 0.75
Cytochalasin-B (19) 0.60 0.01 0.58 0.02 0.22 0.25
Iodoacetate (34) 0.83 0.0001 0.74 0.0001 0.0001 0.17
Sodium fluoride (28) 0.85 0.0001 0.60 0.001 0.0001 0.73
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presence of 1.6 nm insulin (Dglucose, 0.7 6 0.1 mmol/liter).
Overall, the leptin response was inversely related to the
concentration of phloretin and was highly correlated with
the decrease in glucose in the medium (Table 1). However,
by multiple regression, the leptin response was correlated
with the decrease in glucose, but not with the concentration
of phloretin (Table 1). The addition of 55.5 mm glucose at 48 h
did not reverse the inhibition of leptin secretion by phloretin
(Fig. 3).
Effects of cytochalasin B
The effect of inhibiting glucose uptake with cytochalasin
B on leptin secretion was examined. Cytochalasin B pro-
duced a concentration-dependent inhibition of glucose up-
take and leptin secretion (Fig. 4). The leptin response was
significantly correlated with glucose uptake by simple re-
gression (Table 1), but was not significantly correlated with
glucose uptake (as observed with the other inhibitors; Table
1) by multiple regression, perhaps due to the smaller number
of replicates (n 5 19) in this experiment.
Effects of iodoacetate (0.005–1.0 mM)
The effect of inhibiting glycolysis with iodoacetate on lep-
tin secretion was examined. Iodoacetate at 1.0, 0.1, and 0.01
mm markedly inhibited glucose uptake (Dglucose, 20.1 6
1.1, 0.5 6 0.2, and 0.3 6 0.2 mmol/liter, respectively) and
leptin secretion. The 0–96 h AUC for leptin was inhibited by
295 6 2%, 291 6 2%, and 287 6 3%, respectively, compared
with insulin alone; (all P , 0.0001). The lowest concentration
of iodoacetate (0.005 mm) produced less of an inhibition of
glucose uptake (Dglucose, 21.8 6 0.8 mmol/liter) and less of
an inhibition of leptin secretion (251.0 6 16%) than insulin
alone (P , 0.02; Fig. 5). By simple regression, the release of
leptin was related to the concentration of iodoacetate and
was highly correlated with the change in glucose in the
medium (Table 1). However, by multiple regression, the
leptin secreted at 96 h was related to the change in glucose,
but not to the concentration of iodoacetate (Table 1).
Effects of NaFl (0.1–5.0 mM)
The effect of inhibiting glycolysis with NaFl was exam-
ined. The two highest concentrations of NaFl (5.0 and 1.0
mm) completely inhibited glucose uptake (Dglucose, 0.2 6
0.1 and 0.0 6 0.3 mmol/liter, respectively). The 0.5 mm con-
centration of NaFl produced less of an inhibition of glucose
uptake (D, 22.1 6 0.6 mmol/liter), and the lowest concen-
tration (0.1 mm) of NaFl did not inhibit glucose uptake (Dglu-
cose, 23.9 6 0.5 mmol/liter) compared with the effect of
insulin alone. The two highest concentrations of NaFl (5.0
and 1.0 mm) markedly inhibited leptin secretion (281 6 6%
vs. insulin alone; P , 0.0001). The next concentration of NaFl
(0.5 mm) produced an intermediate inhibition of leptin se-
cretion (247 6 15% of insulin alone; P , 0.05). The 0.1-mm
concentration of NaFl did not inhibit leptin secretion (24 6
15% vs. insulin alone; P 5 NS; Fig. 6).
Overall, the decline in medium glucose was significantly
FIG. 6. Effects of inhibiting glycolysis with NaFl on leptin concen-
trations from 0–96 h in medium from isolated rat adipocytes in pri-
mary culture for 96 h with 1.6 nM insulin.
FIG. 4. Effects of inhibiting glucose transport with cytochalasin B on
leptin concentrations from 0–96 h in medium from isolated rat adi-
pocytes in primary culture for 96 h with 1.6 nM insulin.
FIG. 5. Effects of inhibiting glycolysis with iodoacetate on leptin con-
centrations from 0–96 h in medium from isolated rat adipocytes in
primary culture for 96 h with 1.6 nM insulin.
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correlated with the concentration of NaFl and highly corre-
lated with the 96 h leptin concentration (Table 1). By multiple
regression, the amount of leptin secreted at 96 h was strongly
correlated with the change in glucose in the medium (P ,
0.0001), but not to the NaFl concentration (Table 1).
Effects of insulin, 2-DG, and NaFl on leptin (ob) mRNA
and 18S ribosomal RNA
The effects of inhibiting glucose uptake and metabolism
with 2-DG or NaFl on leptin gene expression and ribosomal
18S RNA were examined. As shown in Fig. 7A, leptin (ob)
mRNA was detectable in adipocytes incubated for 48 h either
with 1.6 nm insulin or without insulin (control). However, the
leptin mRNA signal was reduced to near undetectable levels
when adipocytes were incubated with 1.6 nm insulin and
either 2-DG (10 mg/ml) or 1.0 mm NaFl (Fig. 7A). The effect
of 2-DG and NaFl was specific, because in the same samples
there was no effect of these concentrations of 2-DG or NaFl
on 18S ribosomal RNA (Fig. 7B) or on nonspecific RNA bands
(with a different mol wt than leptin mRNA) that could be
detected on the Northern blots after long exposures (data not
shown). Leptin mRNA was significantly reduced by 2-DG or
NaFl regardless of whether the signal was normalized for 18S
ribosomal signal (P 5 0.0174). Qualitatively similar effects of
2-DG or NaFl were observed in cultures incubated for 96 h
(P 5 0.0228; data not shown).
Effects of fructose (5 mM)
The addition of 5 mm fructose to medium of cultures in
which the glucose concentration was minimized by diluting
the Matrigel 1:2 and using glucose-free DMEM with 1%
serum augmented leptin secretion after 48 h. The initial re-
sponse in the control wells was probably due to the residual
glucose (;1.5 mmol/L) in the diluted Matrigel. However,
both the integrated AUC from 0–96 h (P , 0.02) and the
leptin concentration at 96 h (P , 0.01) were increased by
fructose (Fig. 8).
Discussion
In the present study we found that addition of physio-
logical concentrations of insulin stimulates leptin secretion
from isolated rat adipocytes in primary culture. In this in vitro
system we did not see an acute effect of insulin on leptin
secretion. This is in agreement with previous reports that
have demonstrated that the expression of ob gene and leptin
protein release are not acutely regulated by insulin in vivo
and in vitro (17, 36). The strong correlation between adipocyte
glucose uptake measured by the decrease in glucose in the
media during incubation with insulin and the amount of
FIG. 7. A, Effects of no insulin (control), 1.6 nM insulin, and 1.6 nM
insulin plus 10 mg/dl 2-DG or 1.0 mM NaFl on leptin (ob) mRNA after
48 h of incubation, as assessed by Northern blots. The inset above each
bar is representative of the signal obtained for each condition. B,
Effects of control (no insulin), 1.6 nM insulin, and 1.6 nM insulin plus
10 mg/dl 2-DG or 1.0 mM NaFl on 18S ribosomal RNA after 48 h of
incubation, as assessed by Northern blots. The inset above each bar
is representative of the signal obtained for each condition.
FIG. 8. Effect of fructose (5 mM) on leptin concentrations from 0–96
h in medium from isolated rat adipocytes in primary culture with a
low (;1.5 mmol/liter) initial glucose concentration (n 5 6/treatment).
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leptin secreted from isolated adipocytes is consistent with the
hypothesis that the rate of glucose metabolism is a determi-
nant of leptin secretion. In addition, the absolute insulin
concentration was not related to the leptin response, inde-
pendently of the effect of insulin to increase glucose uptake.
Blockade of glucose transport with 2-DG, phloretin, or
cytochalasin B at concentrations at or below those typically
used in adipocytes (29, 30) produced a dose-dependent de-
crease in leptin secretion in the presence of high physiolog-
ical concentrations of insulin. The competitive inhibition pro-
duced by 2-DG could be reversed by the addition of a high
concentration of glucose, suggesting that 2-DG did not in-
hibit leptin secretion via a nonspecific toxic effect on the
adipocytes. As expected, the inhibition by phloretin was not
reversed by glucose, as phloretin is not a competitive inhib-
itor and, therefore, produces an irreversible inhibition of
glucose transport that is not readily overcome by high glu-
cose concentrations. These experiments provide evidence
that glucose uptake is required to increase leptin secretion
from isolated adipocytes despite the presence of high phys-
iological insulin concentrations.
Inhibition of glycolysis with either iodoacetate or NaFl at
low concentrations (31, 32) also produced concentration-
dependent inhibition of leptin secretion in the presence of
insulin. When glycolysis is inhibited, glycolytic intermedi-
ates accumulate, resulting in a secondary impairment of glu-
cose uptake. As with primary blockade of glucose uptake,
during inhibition of glucose metabolism by either glycolytic
inhibitor, the amount of glucose taken up over 96 h of in-
cubation was highly correlated with the amount of leptin
secreted despite the presence of insulin. These results suggest
that the stimulation of leptin secretion by insulin is unlikely
to be due to a direct effect of insulin per se, but is secondary
to the effect of insulin to stimulate glucose uptake and me-
tabolism in adipocytes.
We also found that inhibition of glucose transport and
metabolism with 2-DG or glycolysis with NaFl markedly
inhibited leptin (ob) gene expression, as assessed by Northern
blot analysis of leptin mRNA. In the same cultures, 18S
ribosomal RNA levels were unaffected by either 2-DG or
NaFl, suggesting that the decrease in leptin gene expression
was not due to a nonspecific overall effect of these inhibitors
to impair adipocyte RNA synthesis. In addition, we exam-
ined the amount of heparin-released lipoprotein lipase (LPL)
from adipocytes cultured with the various inhibitors (data
not presented). Although LPL was modestly decreased by
the inhibitors (;25–50% of insulin-stimulated levels), the
suppression of leptin secretion was significantly greater (80–
90%), suggesting a relative specificity of blocking glucose
uptake and metabolism on leptin secretion vs. that on another
protein (LPL) produced by adipose tissue. Lastly, the effects
of the blockers to inhibit leptin expression and secretion are
unlikely to be due to a depletion of adipocyte energy stores,
as it is known that adipocytes can generate energy (ATP) by
oxidizing fatty acids via mitochondrial b-oxidation (37, 38).
Taken together, these data suggest a physiological role for
glucose in the regulation of leptin expression and secretion
by adipocytes. Accordingly, we hypothesize that during fast-
ing, when circulating insulin and glucose concentrations are
low and glucocorticoids are elevated, leptin secretion de-
clines secondary to decreased glucose transport into adipose
tissue. Upon refeeding, increases in circulating insulin and
glucose and the resulting increases in adipose glucose uptake
and metabolism stimulate leptin secretion and restores cir-
culating leptin concentrations to prefasting levels. This
model, therefore, can explain the effects of fasting and refeed-
ing on circulating leptin in humans (2–4) and rodents (5–7).
In addition, the nocturnal increase in plasma leptin observed
in humans could potentially arise as a delayed consequence
of increased insulin-stimulated glucose metabolism follow-
ing meals (8). The effect of glucose infusions to prevent the
fall of plasma leptin during fasting in human subjects may
be similarly mediated (2).
Thus, leptin secretion appears to reflect the amount of
glucose transported and metabolized by adipose tissue.
There is convincing evidence that suggests that a significant
portion of glucose entering adipose tissue is metabolized to
lactate and released (34, 35). This lactate may contribute to
the pool of gluconeogenic precursors during fasting. Our
results show that when a smaller proportion of glucose car-
bon taken up by adipocytes is released as lactate, more leptin
is secreted. These data are consistent with the changes in
leptin secretion observed during fasting and refeeding. In
addition, fructose, in the presence of low glucose concentra-
tions, stimulates leptin secretion, demonstrating that a non-
glucose substrate can induce the adipocyte to secrete leptin
and suggesting that stimulation of leptin secretion by glucose
metabolism occurs downstream of phosphofructokinase.
In summary, blockade of glucose transport or inhibition of
glycolysis inhibits leptin secretion from and gene expression
in isolated cultured adipocytes. The secretion of leptin is
directly proportional to the amount of glucose taken up by
the adipocytes. These results suggest that leptin secretion is
linked to glucose transport and metabolism and help to ex-
plain the known effects of feeding/fasting and long term
glucose and insulin administration on circulating leptin
concentrations.
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